Parameter | Control | Patients | ||
---|---|---|---|---|
Before% | During% | After% | ||
Hb (g/dl) | ||||
Min. – Max. | 11.3–16.3 | 11.1–14.8 | 8.75–11.0 | 8.4–12.4 |
Mean ± SD. | 14.55 ± 2.43 | 12.72 ± 1.55 | 10.15 ± 1.18 | 10.3 ± 1.0 |
pControl | 0.732 | 0.824 | 0.643 | |
WBCs/mm3 | ||||
Min. – Max. | 4750.0–10750.0 | 4.000–14750.0 | 3420.0–5500.0 | 2020.0–3700.0 |
Mean ± SD. | 7254 ± 2245.0 | 9062.0 ± 2349.0 | 3725.0 ± 1724.0 | 2550.0 ± 450.9 |
pControl | < 0.05* | < 0.05* | < 0.01* | |
PL/mm3 | ||||
Min. – Max. Mean ± SD. | 150000.0–420000.0 2,770,833 ± 8730.9 | 120000.0–138000.0 128000.0 ± 1073.0 | 33,000–52,000 35,000 ± 1439 | 35400.0–38000.0 26,625 ± 29,217 |
pControl | 0.034* | 0.027* | 0.012* | |
PBMCs / ml after Ficol | ||||
Min. – Max. | 1.27–1.37 | 0.53–1.50 | 0.47–0.65 | 0.48–2.50 |
Mean ± SD. | 1.31 ± 0.05 | 1.01 ± 0.44 | 0.60 ± 0.08 | 1.17 ± 0.85 |
pControl | 0.310 | 0.008* | 0.690 | |
Lymph % | 31.5 | 69.36 | 54.95 | 49.85 |
Lymph (103) | 2.6 | 2.84 | 1.48 | 0.77 |
Mono % | 3 | 8.4 | 7.8 | 6.025 |
Mono (103) | 0.255 | 0.344 | 0.210 | 0.093 |
Gran % | 60 | 22.64 | 39.025 | 42.313 |
Gran (103) | 5.1 | 0.92 | 1.05 | 0.65 |